Nevro Investor Relations Material
Latest events
Q3 2024
Nevro
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Nevro Corp
Access all reports
Nevro Corp. is a medical device company specializing in developing and commercializing solutions for the treatment of chronic pain. The company’s primary product is the Senza spinal cord stimulation (SCS) system, which utilizes proprietary high-frequency technology to manage pain without causing paresthesia. The company is headquartered in Redwood City, California, and its shares are listed on the NYSE.
Key slides for Nevro Corp
Q2 2024
Nevro Corp
Q1 2024
Nevro Corp
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
NVRO
Country
🇺🇸 United States